Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (54)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bradley, K. M.
Right arrow Articles by Shepstone, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bradley, K. M.
Right arrow Articles by Shepstone, B. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 125, No. 8, 1772-1781, August 2002
© 2002 Guarantors of Brain

Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer’s disease

K. M. Bradley1, V. T. O’Sullivan2, N. D. W. Soper2, Z. Nagy1, E. M.-F. King1, A. D. Smith1 and B. J. Shepstone2

1 Oxford Project to Investigate Memory and Ageing (OPTIMA), Department of Pharmacology and Radcliffe Infirmary, 2 Department of Radiology, Radcliffe Infirmary, University of Oxford, Oxford, UK

Correspondence to: K. M. Bradley, OPTIMA, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK E-mail: kevin.bradley{at}radiology.ox.ac.uk

Reductions in regional cerebral perfusion, particularly in the posterior temporo-parietal lobes, are well recognized in Alzheimer’s disease. We set out to correlate perfusion changes, using 99mTc-HMPAO single photon emission tomography (SPET), with the pathological stage of Alzheimer’s disease. The ‘Braak stage’ of the distribution of neurofibrillary pathology in post-mortem brains was used to classify SPET scans taken in life from a mixed (dementia and control) elderly population into the entorhinal stage (n = 23 subjects), limbic stage (n = 30 subjects) and neocortical stage (n = 36 subjects) Alzheimer’s disease pathology. The SPET scans were then registered to a common, standard Talaraich space, and single template scans produced for each pathological stage. Comparison of these templates revealed an evolution in the pattern of reduction in regional perfusion. Additional comparisons were performed using earlier SPET scans obtained 5 years before death. For comparisons between templates, a threshold of 10% perfusion change was chosen so as to be clinically relevant as well as statistically significant. Reduced perfusion appears between the entorhinal and limbic stages in the anterior medial temporal lobe, subcallosal area, posterior cingulate cortex, precuneus and possibly the supero-anterior aspects of the cerebellar hemispheres. Large posterior temporo-parietal perfusion defects then appear between the limbic and neocortical stages, before finally large frontal lobe perfusion defects. The time course of these perfusion defects appears relatively long, suggesting that perfusion changes may have scope to be a diagnostic aid in staging Alzheimer’s disease in life. The reduction in anterior medial temporal lobe perfusion may have future relevance on modern high resolution SPET and PET systems and also perfusion-type MRI sequences.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BrainHome page
M. Fouquet, B. Desgranges, B. Landeau, E. Duchesnay, F. Mezenge, V. de la Sayette, F. Viader, J.-C. Baron, F. Eustache, and G. Chetelat
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease
Brain, August 1, 2009; 132(8): 2058 - 2067.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
W. Dai, O. L. Lopez, O. T. Carmichael, J. T. Becker, L. H. Kuller, and H. M. Gach
Mild Cognitive Impairment and Alzheimer Disease: Patterns of Altered Cerebral Blood Flow at MR Imaging
Radiology, March 1, 2009; 250(3): 856 - 866.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
V. Garibotto, B. Borroni, E. Kalbe, K. Herholz, E. Salmon, V. Holtoff, S. Sorbi, S. F. Cappa, A. Padovani, F. Fazio, et al.
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence
Neurology, October 21, 2008; 71(17): 1342 - 1349.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. L. Whitwell, K. A. Josephs, M. E. Murray, K. Kantarci, S. A. Przybelski, S. D. Weigand, P. Vemuri, M. L. Senjem, J. E. Parisi, D. S. Knopman, et al.
MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study
Neurology, September 2, 2008; 71(10): 743 - 749.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. Bentley, J. Driver, and R. J. Dolan
Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health
Brain, February 1, 2008; 131(2): 409 - 424.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Matsuda
Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT
J. Nucl. Med., August 1, 2007; 48(8): 1289 - 1300.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K A Johnson, E K Moran, J A Becker, D Blacker, A J Fischman, and M S Albert
Single photon emission computed tomography perfusion differences in mild cognitive impairment
J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 240 - 247.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. Prohovnik, D. P. Perl, K. L. Davis, L. Libow, G. Lesser, and V. Haroutunian
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
Neurology, January 10, 2006; 66(1): 49 - 55.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
N. A. Johnson, G.-H. Jahng, M. W. Weiner, B. L. Miller, H. C. Chui, W. J. Jagust, M. L. Gorno-Tempini, and N. Schuff
Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience
Radiology, March 1, 2005; 234(3): 851 - 859.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
Y Nagahama, T Okina, N Suzuki, H Nabatame, and M Matsuda
The cerebral correlates of different types of perseveration in the Wisconsin Card Sorting Test
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 169 - 175.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Drzezga, M. Riemenschneider, B. Strassner, T. Grimmer, M. Peller, A. Knoll, S. Wagenpfeil, S. Minoshima, M. Schwaiger, and A. Kurz
Cerebral glucose metabolism in patients with AD and different APOE genotypes
Neurology, January 11, 2005; 64(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. D. Greicius, G. Srivastava, A. L. Reiss, and V. Menon
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI
PNAS, March 30, 2004; 101(13): 4637 - 4642.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P M Kemp, C Holmes, S Hoffmann, S Wilkinson, M Zivanovic, J Thom, L Bolt, J Fleming, and D G Wilkinson
A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, November 1, 2003; 74(11): 1567 - 1570.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.